Fields and levels of expertise relevant to the work of the Committee
for Risk Assessment
Nomination for the Committee for Risk Assessment
Name of the candidate:
Member State nominating the candidate:
The nominated candidates for the Committe for Risk Assessment are expected to have in-depth expertise in
at least one of the following fields and for a number of other fields they should have some experience
themselves and/or have access to in-depth expertise in their national institutions or authorities.
The candidates are asked to fill in the grid below by entering a figure 1 in the relevant boxes according to the
person's areas of expertise. The Excel spreadsheet has been developed to facilitate the generation of an
overview of all the candidates, and should be returned in electronic format.
Fill in '1' if applicable to any of the shaded boxes
I Risk Assessment and C&L
Access to in-
In-depth Know- Some general depth expertise
Field of expertise/experience
expertise ledgeable knowledge at national
level
(1) Human Health
Toxicology
Reproductive toxicity
Mutagenicity
Genotoxicity
Carcinogenicity
Respiratory sensitization
Local effects (skin/eye irritation/corrosion)
Immunotoxicity
Assessment of endocrine disrupting properties
In vitro cell toxicology
Toxicokinetics, metabolism
Biomonitoring (effects/exposure)
Human exposure assessment (monitoring/models)
Exposure of humans via the environment
Epidemiology
Occupational health
Occupational hygiene
Regulatory human health risk assessment,
Classification and labelling of dangerous substances under
67/548/EEC, preparations directive and GHS
(Quantitative) Structure Activity Relationships - (Q)SARS
Other modelling
Test method development and the development of test
protocols to address specific information needs
(Bio)statistics
Other (please specify)
Page 1 of 3
Access to in-
In-depth Know- Some general depth expertise
Field of expertise/experience
expertise ledgeable knowledge at national
level
(2) Environment
Ecotoxicology:
Aquatic compartment
Sediment compartment
Soil compartment
Avian toxicity
Assessment of endocrine disrupting properties
Environmental fate and behaviour:
Abiotic degradation
Biotic degradation
Long range atmospheric transport
Soil chemistry
Aquatic chemistry
Bioaccumulation potential
PBT/POP assessment
Environmental Exposure assessment
Environmental monitoring
Environmental exposure models and modelling
Regulatory environmental risk assessment
Classification and labelling of dangerous substances under
67/548/EEC, preparations directive and GHS
(Quantitative) Structure Activity Relationships - (Q)SARs
Test method development and the development of test
protocols to address specific information needs
(Bio)statistics
Other (please specify)
Physico-chemical properties
Chemistry
Analytical chemistry
Organic chemistry
Inorganic chemistry
Assessment of physico-chemical properties and risks
Classification and labelling of dangerous substances under
67/548/EEC, preparations directive and GHS.
Substance identification
Test method development and the development of test
protocols to address specific information needs
Interaction of the test results of physico-chemical properties
with toxicological/ecotoxicological studies
Other (please specify)
Page 2 of 3
II Risk Management
Access to in-
In-depth Know- Some general depth expertise
Field of expertise/experience
expertise ledgeable knowledge at national
level
REACH exposure scenarios; knowledge on the risk
management measures and operational conditions,
especially on their practicability and effectiveness, related
to
Environment
Occupational health and hygiene
Consumer protection
Risk reduction of different risk management options
- Regulatory risk management
Experience in the regulatory risk management of
chemicals under chemicals legislation
Experience in the regulatory risk management of
chemicals under consumer legislation
Experience in the regulatory risk management of
chemicals under environmental legislation
Experience in the regulatory risk management of
chemicals under occupational health legislation
Other experience in the regulatory risk management
of chemicals (please specify)
- Other risk management options
Economic instruments
Voluntary approaches
Communication and information
Others (please specify)
III Cross-cutting issues
Access to in-
In-depth Know- Some general depth expertise
Field of expertise/experience
expertise ledgeable knowledge at national
level
Knowledge of issues related to the requirements of REACH
titles VI, VII, VIII and harmonised C+L (CLH)
Knowledge of key issues falling under the responsibility of
the Committee for Socio-economic Analysis
Knowledge of key issues falling under the responsibility of
the Member States Committee
Page 3 of 3
Annex 6
Helsinki, 27 March 2018
BACKGROUND PAPER
Committee for Socio-economic Analysis
1 Introduction
The Committee for Socio-economic Analysis (SEAC) of the European Chemicals Agency
(ECHA) plays an important role in the key REACH 1 processes concerning restrictions and
authorisations. Furthermore, it delivers opinions on any other aspect that arise from the
operation of REACH relating to the socio-economic impacts of possible legislative action
on substances.
This document has been developed to support the Member States (MSs) in the process of
renewal of memberships of SEAC, and/or of nominating new candidates. It provides
details on the expected workload of the members and the level of support required from
their nominating Member State. Finally the paper presents an overview of the fields of
expertise to be covered in SEAC.
2 Composition, role and tasks of the Committee for Socio-economic Analysis
SEAC is composed of members appointed by the Management Board based on
nominations made by the Member States and EEA-EFTA countries. In addition to
members, SEAC can co-opt up to five additional members. At the moment there are 36
members.
In accordance with Article 77(1) of the Regulation, the task of ECHA is to provide the
best possible scientific and technical advice on questions related to chemicals. The ECHA
Committees (RAC, SEAC and MSC) are an essential part of the smooth functioning of
REACH. The tasks of SEAC are described in REACH in Article 76(1)(d).
SEAC formulates an ECHA opinion in relation to the following:
• Authorisation – Assessing the socio-economic factors related to the application
for authorisation and the availability and technical and economic feasibility of
alternatives.
• Restrictions – Assessing the proposed restriction and its socio-economic impact.
In addition, the Executive Director of ECHA may ask SEAC to draw up an opinion on any
other aspects concerning the safety of substances on their own, in preparations or in
articles (Article 77(3)(b) and (c)).
1
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration,
Evaluation, Authorisation, and Restriction of Chemicals (REACH).
1(2)
Annex 6
3 Working procedures
There are fixed, tight deadlines for the delivery of SEAC’s opinions, and consequently the
committee will be under time pressure to deliver its opinions.
Article 87(1) stipulates that the Committee shall appoint one of its members as a
rapporteur in order to draft its opinions. Further to this, a co-rapporteur may be
appointed.
SEAC is chaired by an ECHA staff member, Dr. Tomas Öberg, and is supported by a
committee secretariat provided by ECHA.
4 Expectations of expertise for the SEAC members
The REACH Regulation makes it clear that members of the Committees must possess the
necessary qualifications in order to allow the Committees to meet the high expectations
put on them. A grid concerning fields and level of relevant expertise to SEAC is enclosed
to this document (see the separate Excel-file ‘SEAC Expertise Grid.xls’).
Key areas of expertise required
The three key areas of specialised expertise required by the Committee are:
• Economics, in particular welfare, public sector, environmental or health
economics;
• Methodologies analysing costs and benefits of regulation, including the analysis of
technical feasibility of alternatives and their costs;
• Knowledge about substitution and substances of concern, such as SVHCs.
Each of the members of SEAC need to possess the expertise and the language skills
necessary for actively participating in drafting, commenting and discussing opinions on
proposals for restrictions and applications for authorisation.
Support for member’s activities
In accordance with Article 85(6) of the REACH Regulation, Member States are obliged to
support the SEAC members by providing adequate scientific and technical resources to
them. A 50% commitment is required from all SEAC members who share their
responsibilities, which include acting as dossier (co-)rapporteurs, contributing to the
discussions at SEAC with timely comments and participating in other SEAC activities such
as working groups.
Reimbursement
ECHA reimburses the travel and accommodation expenses and pays subsistence
allowance to the members and, where relevant, remunerates the rapporteur and co-
rapporteur for the work undertaken in line with the rules adopted by the Management
Board (MB/45/2014).
5 Further considerations
SEAC meetings are held four times a year, typically for up to five full days, and the
provisional dates are published on the Committee pages of the ECHA website at least a
year in advance. The actual number and duration of meetings will naturally depend on
the workload of the Committee.
Considering the above, it is estimated that the SEAC member should expect to
work half time with SEAC related issues in the coming three years.
2(2)
Annex 4
Helsinki, 27 March 2018
BACKGROUND PAPER
Member State Committee
1 Introduction
The Member State Committee (MSC) of the European Chemicals Agency (ECHA) is
responsible for resolving potential divergences of opinions on draft decisions proposed by
ECHA or the Member States (MSs) on dossier and substance evaluation and on proposals
for identification of substances of very high concern. MSC thus has an important role in
the key REACH 1 processes concerning evaluation and authorisation.
MSC is composed of members appointed directly by each of the 28 Member States and
the three EEA-EFTA countries. Only the members appointed by MSs have the right to
vote. Alternate members may also be appointed by MSs.
This document has been developed to support MSs in appointing the most suitable
member to MSC, or renewing the membership of the current member by outlining the
expectations of expertise for the MSC members. Further background on MSC’s role, tasks
and operation is provided in Appendices. Members are expected to dedicate at least 30%
of their work time to MSC.
2 Expectations of expertise for the MSC members
The REACH Regulation makes it clear that members of the Committees must possess the
necessary qualifications in order to allow the Committees to meet the high expectations
put on them.
MSC delivers an opinion on some REACH processes and seeks unanimous agreement on
dossier and substance evaluation and identification of Substances of Very High Concern
for authorisation. To deal with the different tasks, a range of expertise is required within
MSC to ensure that all aspects concerning these issues can be addressed.
Given the complexity of the tasks, the members of MSC need to have relevant
experience and expertise in the many science areas for which MSC is responsible. Ideally,
they should themselves cover one or several areas of expertise at expert level, and for a
number of other areas they should either have some experience themselves and/or have
access to in-depth expertise. Moreover, the members should have good understanding of
the REACH requirements and regulatory science as well as have sufficient resources
available for the Committee work. They should also possess the necessary negotiating
skills to solve any divergences of views in an efficient manner.
Each of the members of MSC should possess, or have access to, the necessary expertise
for drawing up opinions and unanimous agreements concerning:
1
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration,
Evaluation, Authorisation, and Restriction of Chemicals (REACH)
1(5)
• evaluation of testing proposals or requirements for additional information required
under dossier evaluation;
• compliance checks and examination of additional information required under
dossier or substance evaluation;
• community rolling action plan for substances which could constitute a risk to
human health or the environment; and
• identification of substances of very high concern and prioritising them for
authorisation.
MSC is also expected to revise and further develop methodology regarding its field of
competence and to give input to guidance updates.
To ensure sufficient coverage of all required expertise areas (including but not limited to
repeat-dose toxicity, mutagenicity, reproductive toxicity, aquatic and terrestrial toxicity,
PBT-assessment, endocrine disruption, sensitisation, environmental fate and behaviour,
exposure and risk assessment), members may be accompanied to the meetings by
advisors or experts.
In accordance with Article 85(6) of the REACH Regulation, MSs are obliged to support the
MSC members by providing adequate scientific and technical resources to them. ECHA
reimburses the travel and accommodation expenses and pays subsistence allowances to
the members.
3 Further appointment considerations
In addition to experience in one or more of the areas listed above, MSs are requested to
give preference to candidates who possess significant experience at least in one,
preferably several, of the following areas:
• Experience in national and EU chemicals management policy;
• Overall good knowledge and understanding of the legal requirements of the
REACH Regulation, its policy objectives and the balance between these objectives;
• Experience in drafting regulatory or legislative decisions and to defend these in
front of expert audiences;
• Experience in carrying out scientific and/or regulatory risk assessments;
• International experience in discussing chemical hazard or risk assessment; and/or
• Experience in the EU committee work on chemicals.
In addition to the qualifications and expertise of members, the functioning of MSC
requires that members attend the meetings which are held in Helsinki, Finland at ECHA’s
premises on a regular basis. This includes preparation time for the plenary meetings,
which, depending on the number of dossiers can be considerable. All MSC members
share the responsibility to act as rapporteurs, to participate in other MSC activities such
as working groups, and join in the debate and provide interventions in plenary sessions
of MSC. Additionally, a considerable demand on a MSC member’s time is stemming from
written procedures used for agreement seeking in between plenary meetings. MSC
members should be entitled to dedicate sufficient working time to MSC activities - at
least 30% of their time.
Plenary meetings of MSC are held 5-6 times per year, typically for three to five full days.
MSC has, since its start in February 2008 until March 2018 held 58 meetings. The actual
number and duration of meetings will depend on the workload, on the operating
procedures and on the output of any potential working groups.
2(5)
Appendix 1: Composition, role and tasks of the Member State Committee
MSC is composed of members appointed directly by each of the 28 Member States and
the three EEA-EFTA countries. Only the members appointed by MSs have the right to
vote.
In order to ensure smooth functioning and decision making in MSC, two specific
arrangements are in place with MSC: 1) MSs may appoint an alternate member who can
replace the appointed member when he/she is not in attendance at the meeting or
available to respond to requests in written consultation. 2) MSC has agreed on
arrangement of proxy vote in case a member with voting right or her/his alternate is
absent from a meeting.
In accordance with Article 77(1) of the Regulation, the task of ECHA is to provide the
best possible scientific and technical advice on questions related to chemicals. MSC plays
an important role to achieve this: The Committee has a conciliatory role, aiming i.a. to
solve divergences of opinions and reach agreement amongst Member States' authorities
on specific issues which require a harmonised approach, thus allowing ECHA to take
decisions efficiently.
The tasks of MSC are described in REACH in Art. 76(1)(e). An overview of the MSC tasks
is provided below.
1. Evaluation
MSC has essential role in
Dossier evaluation:
• Seeking agreement when the examination of testing proposals or additional
information required under dossier evaluation results in draft decisions to which
amendments are proposed by MSs;
• Seeking agreement when the compliance check results in a draft decision to which
amendments are proposed by MSs;
Substance evaluation:
• Seeking agreement when a MS or ECHA has proposed to amend the draft decision
on substance evaluation;
• Providing an opinion on a draft update of the Community rolling action plan
prepared by the ECHA Secretariat for substances which could constitute a risk to
human health or the environment;
• Providing an opinion on whether or not to add a substance to the Community
rolling action plan following proposals from a MS; and
• Seeking agreement in cases where two or more MSs have expressed an interest in
evaluating the same substance.
Currently the tasks related to dossier and substance evaluation decision making form a
major workload for MSC.
2. Authorisation
MSC has essential role in:
• Seeking agreement on the identification of substances of very high concern to be
included on the candidate list (SVHCs) for potential inclusion in Annex XIV (list of
substances subject to authorisation); and
• Providing opinions on draft recommendations prepared by the ECHA Secretariat
on priority substances to be included in Annex XIV.
3(5)
So far MSC has considered over 140 proposals for identification of SVHCs, unanimously
agreed on 127 of them and provided eight opinions on ECHA’s draft recommendations of
priority substances. These will remain as regular tasks in the work program of MSC.
In addition, the Executive Director of ECHA may request MSC to provide technical and
scientific support to improve cooperation between the Community, its MSs, international
organisations and third countries on scientific and technical issues relating to the safety
of substances, as well as active participation in technical assistance and capacity building
activities on sound management of chemicals in developing countries. MSC may also be
asked to draw up an opinion on any other aspects concerning the safety of substances on
their own, in preparations or in articles.
The work of MSC, including agendas and minutes of the meetings, may be consulted
from http://echa.europa.eu/web/guest/about-us/who-we-are/member-state-committee
4(5)
Appendix 2 - Working procedures of the Committee
There are fixed, in some cases very short (30 days) deadlines for the delivery of the MSC
tasks. By default the majority of the cases that are brought to MSC are difficult in the
sense that there are diverging views among the MSs or comments have been made on
an issue. However, ECHA Secretariat provides MSC with all the necessary background
information to support it in its agreement seeking either in the form of a proposal for a
revised draft evaluation decision or otherwise.
In each case if an agreement is not found within the deadline, ECHA will refer the case to
the Commission decision making. However, MSC would have to adopt a view on the issue
and record any minority views.
The Rules of Procedure of MSC 2 specify many aspects of the Committee’s operations, for
example procedures for delegating certain tasks to working groups and use of written
procedures. In addition, MSC has established specific working procedures for most of it
tasks 3.
MSC is chaired by ECHA staff member, Mr Watze de Wolf, and is supported by a
Committee Secretariat provided by ECHA. The Secretariat is in particular:
• organising the Committee meetings;
• co-ordinating work within the Agency and with the other ECHA Committees, and
promoting consistency of the decisions within and between the committees;
• keeping a Manual of Decisions and Opinions based on conclusions from MSC
regarding interpretation and implementation of REACH; and
• organising the follow-up of the MSC decisions.
2
MSCs Rules of procedure may be consulted at the following link
3
The working procedures of MSC may be consulted at the following link
5(5)
Annex 5
Helsinki, 27 March 2018
BACKGROUND PAPER
Committee for Risk Assessment
1 Introduction
The Committee for Risk Assessment (RAC) of the European Chemicals Agency (ECHA) is
the largest risk assessment committees in Europe. Its tasks under the REACH 1 and CLP 2
processes require an in-depth scientific knowledge and expertise on a variety of specific
disciplines.
This document has been developed to support the Member States (MSs) in nominating,
the best candidates to RAC. It provides details on the tasks and expected workload of the
members and the level of support required from their nominating members state. Finally
the paper concludes with an overview of the fields of expertise needed by the members
of RAC.
2 Composition, role and tasks of the Committee for Risk Assessment
RAC is composed of members appointed by the Management Board based on
nominations made by the Member States and EEA-EFTA countries. In addition, RAC can
co-opt up to five additional members. At the moment there are 54 members (including 4
co-opted members).
In accordance with Article 77(1) of the REACH Regulation, the task of ECHA is to provide
the best possible scientific and technical advice on questions related to chemicals. The
ECHA Committees (RAC, SEAC and MSC) are an essential part of the smooth functioning
of REACH.
RAC plays a pivotal role in both the REACH and CLP processes, i.a. concerning
authorisation, restrictions and harmonised classification and labelling (CLH).
RAC formulates an ECHA opinion in relation to the following:
• Authorisation – Assessing the risk (exposures) from the use(s) of a substance to
workers and the environment arising from those uses for which authorisation is
being sought. This includes an assessment of the operational conditions and risk
management measures described in the application (Article 64(4) of the REACH
Regulation);
• Restrictions - Evaluating whether the restrictions proposed by a Member State
or ECHA for a substance are appropriate in reducing the risk to human health
and/or the environment;
• CLH - Evaluating proposals from Member States or manufacturers, importers or
downstream users for harmonised classification and labelling of a substance under
the CLP Regulation).
• OSH – RAC has been requested to provide
1
Regulation (EC) No 1907/2006 , OJ L 396, 30.12.2006 p.1, corrected version in OJ L 136, 29.5.2007, p. 3
2
Regulation (EC) No 1272/2008, OJ L 353, 31.12.2008
1(4)
Annex 5
In addition, and upon specific requests from the Executive Director of ECHA, the
Committee is may be requested to:
• Draw up opinions relating to risks to human health or the environment on any
other aspects concerning the safety of substances on their own, in preparations or
in articles (Article 77 (3) (c) of the REACH Regulation).
• Resolve potential conflicts of opinion with other Community bodies under Article
95.
• e Be consulted on other aspects of risks arising from chemicals and their
management and regularly asked to provide input to ECHA guidance updates.
3 Working procedures
As described above, RAC covers several types of dossiers and processes. Moreover, there
are fixed, tight deadlines for the delivery of opinions, and RAC is under time pressure to
deliver its opinions.
RAC is chaired by an ECHA staff member, Dr Tim Bowmer, and is supported by a
committee secretariat provided by ECHA.
4 Expectations of expertise for the RAC members
The REACH Regulation makes it clear that members must possess the necessary
qualifications in order to allow the Committees to meet the high expectations put on
them.. All potential members should be familiar with the principles of human health
and/or environmental risk assessment.
Key areas of expertise required
The key areas of specialised expertise required by the Committee are presented in the
table below.
Classification Labelling and Packaging (CLP)
• General toxicology
• Ecotoxicology and biodegradation
Restrictions
• Human health and environmental health risk assessment
• Technical aspects of restrictions
• PBT, vPvB
Authorisations and Occupation Health and safety
• Human health risk assessment in particular carcinogenicity
• Occupational hygiene and exposure
• Risk Management Measures and operational conditions
• Epidemiology and occupational medicine
• Indirect exposure (humans via the environment); emissions to air, water,
soil/sediment
RAC members also require a proper knowledge of regulatory science and its use under
REACH CLP and OSH Regulations, related to chemicals. To provide independent scientific
2(4)
Annex 5
advice, the Committee requires expertise from both regulatory scientists and from
academics.
Currently, ECHA is seeking to strengthen the worker protection capacity of RAC
and welcomes nominations from MS for occupational hygienists and
toxicologists, particularly in the areas of carcinogenicity and mutagenicity,
epidemiologists and occupational physicians.
Support for member’s activities
MSCAs should enable RAC members to accomplish their activities in RAC, keeping in
mind the scientific independence of the members as established under Article 85(7) of
the REACH Regulation. To this end, RAC members should be entitled to dedicate a major
part of their working time to RAC activities - at least 50% of their time (See Annex
III)- which may require specific arrangements with the members and their
institutions/employers.
In addition, MSCAs are required to provide adequate scientific and technical support to
their nominated RAC members 3. This support could include the provision of regular
advisers depending on the topic and ad-hoc specialists plus administrative support.
Rapporteurships
Most of the work of RAC is conducted between meetings and consists of drafting by
Rapporteurs and consultation of the Committee’s opinions with the full membership.
According to Article 87(1) of the REACH Regulation, the members of RAC are
expected to serve as (co-) rapporteurs for preparing the opinions of the
Committee. Each member is expected to act as a rapporteurs or co-rapporteur for 3 to
5 dossiers per year during his/her 3-year membership depending on the scale of
individual dossiers, this may be lower or higher.
Written commenting rounds on opinions
All RAC members are expected to provide their comments and views on the different
draft proposals during written consultations and should be fully involved in the opinion-
making process.
Reimbursement
ECHA reimburses the travel and accommodation expenses and pays subsistence
allowance to the members and, where relevant, remunerates the rapporteur and co-
rapporteur for the work undertaken in line with the rules adopted by the Management
Board (MB/45/2014). As no remuneration is considered for the rapporteurs of CLH
dossiers, ECHA has implemented a mechanism for supporting them and thus contributing
to the costs. The participation of one adviser supporting the CLH rapporteur in RAC
meetings where the substance is discussed is reimbursed. Advisers not employed in the
public service of the Member State can also receive an expert remuneration for their
contribution to the meeting.
5 Further considerations
RAC meetings are held four times a year, at present two double (two week) and two
single week meetings; the provisional dates are published on the Committee pages of the
ECHA website at least a year in advance.
Meetings may be held over two weeks, including up to eight full days or may be held in
one single week of four and a half days.
3
Article 85 of REACH
3(4)
Annex 5
4(4)
1 (3)
ANNEXES - Practicalities
You are kindly invited to submit your appointments/nominations no later than 8 May 2018.
to:
[email protected] together with the following information:
• Communication from the Permanent Representation/Mission to the EU
o Email or letter indicating your appointment(s)/nomination(s)
• Nomination form (Annex 3)
o To be signed by the nominating/appointing MSCA/Mission to the EU.
o In case of renewal of appointment of current member, you are invited to either
attach updated versions of the below annexes 5-8 or to confirm (in the form)
that no changes appear since previous submission of these documents.
• Expertise grid (Annexes 5-6, for RAC and SEAC only)
• Declaration of interest (Annex 7)
• Europass CV (Annex 8)
General conditions and independence of members
According to the REACH Regulation 1, the members of the Committees are appointed for a
term of three years which shall be renewable. Members of the MB of ECHA may not be
members of the Committees.
As one element to safeguard the independence, integrity and credibility of the Committees,
ECHA has put in place a policy 2 to manage potential conflicts of interests that could arise in
relation to the membership of ECHA Committees. Potential conflicts of interests will be
assessed on the basis of the information provided and in particular the declaration of
interests. Member States are kindly asked therefore to pay attention to the ECHA policy for
managing potential conflicts of interests, and to respect the established criteria and
guidelines when considering the appointments and nominations to ECHA Committees.
The MB has also adopted eligibility criteria (Annex 9) of the members of these bodies, to be
applied on a case-by-case basis.
Background documents
To support Member States in selecting the most appropriate candidates, I attach background
documents (see Annexes 4, 5 and 6) that describe the three Committees of ECHA with
respect to their tasks, role of members, ways of operation and the foreseeable workload
related to the REACH and CLP processes.
Publication of names, qualifications and declarations
Please note that, according to Article 88(1) of the REACH Regulation, the membership of the
Committees and the professional qualifications of the members shall be made public. If
individual members believe that such publication could place them at risk, they may request
that their names are not made public; the Executive Director shall decide whether to agree to
such requests. Moreover, in accordance with the Rules of Procedure of the Committees, the
annual declarations of interest are published. In addition, for RAC and SEAC the list of
nominees established by the Executive Director shall be published on the Agency’s website 3.
1
Article 85(4)
2
http://echa.europa.eu/web/guest/about-us/the-way-we-work/procedures-and-policies/conflicts-of-interest
3
Articles 85(1) and (2) of REACH
ANNEX 1 2 (3)
ANNEX 1 - Current Members of the Committees whose term of office will end
by 31 December 2018
1. Member State Committee
Country Title Contact Role Organisation End of Term
Federal public
Kelly MSC Service Health, Food
Belgium Ms 16/07/2018
VANDERSTEEN member Chain Safety and
Environment
Dubravka Marija MSC
Croatia Ms Ministry of Health 11/10/2018
KRECOVIC member
MSC
Estonia Ms Jana SAKSA alternate Health Board 02/11/2018
member
Federal Institute for
Helene MSC
Germany Ms Occupational Safety 31/12/2018
FINDENEGG member
and Health (BAuA)
MSC
Environment
Luxembourg Mr Joe HERMES alternate 06/08/2018
Protection Agency
member
MSC Chemicals Office of
Slovenia Ms Petra ČEBAŠEK alternate the Republic of 08/11/2018
member Slovenia
United Amanda MSC Health and Safety
Ms 24/08/2018
Kingdom COCKSHOTT member Executive
MSC
United Health and Safety
Ms Helen McGarry alternate 25/08/2018
Kingdom Executive
member
2. Committee for Risk Assessment
Country Title Contact Organisation End of Term
Stephka
Institute of Biodiversity and
Bulgaria Prof CHANKOVA- 24/09/2018
Ecosystems Research, BAS
PETROVA
Cyprus Dr Kostas ANDREOU Cyprus University of Technology 24/09/2018
Luxembour Luxembourg Institute of Science
Ms Ruth MOELLER 24/09/2018
g and Technology
Portugal Mr João CARVALHO Portuguese Environment Agency 26/09/2018
Ignacio DE LA
Spain Mr Grupo Tragsa - SEPI 16/12/2018
FLOR TEJERO
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu
ANNEX 1 3 (3)
3. Committee for Socio-economic Analysis
Country Title Contact Organisation End of Term
Izabella
Poland Mr RYDLEWSKA- Ministry of Economy 16/06/2018
LISZKOWSKA
Ministry of Environment and
Sweden Ms Maria NORING 16/12/2018
Energy
Italian Ministry of Economic
Italy Mr Stefano Castelli 16/12/2018
Development
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland | Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu
Fields and levels of expertise relevant to the work of the Committee for Socio-
Economic Analysis
Nomination for the Committee for Socio-Economic Analysis
Name of the candidate:
Member State nominating the candidate:
The nominated candidates for the Committee for Socio-economic Analysis are expected to have in-depth expertise in at least
one of the following fields and for a number of other fields they should have some experience themselves and/or have access
to in-depth expertise in their national institutions or authorities.
The candidates are asked to fill in the grid below by entering a figure 1 in the relevant boxes according to the person's area of
expertise. The Excel spreadsheet has been developed to facilitate the generation of an overview of all the candidates, and
should be returned in electronic format.
Fill in '1' if applicable to any of the shaded boxes
I Socio-economic Analysis
Access to in-
Some
In-depth Know- depth
Field of expertise/experience general
expertise ledgeable expertise at
knowledge
national level
(1) Methodologies on Socio-Economic Analysis
Multi-criteria assessment
Cost-effectiveness analysis
Cost-benefit analysis
Other methodological issues related to economics, including economic
modelling such as general equilibrium modelling, discounting, public and
private costs, externalities and distributional issues
Other methodological issues, including Environmental impact
assessment and Life cycle assessment
(2) Assessing costs and benefits
Valuation of changes in costs due to proposed action[1] for
manufacturers, importers, downstream users or consumers
Effects on human health:
Effects of proposed action on human health (eg. morbidity,
mortality)
Effects of proposed action on specific groups
Socio-economic assessment of proposed action on human health,
including valuation of benefits and use of values derived in other
places (i.e. “benefit transfer”)
Effects on the environment:
Effects of proposed action on the environment (see also Committee
for Risk Assessment)
Socio-economic assessment of proposed action on the
environment, including valuation of benefits and use of values
derived in other places (i.e. “benefit transfer”)
(3) Availability of alternatives
Cost and economic feasibility of alternatives
Technical feasibility of alternatives
Future trends in the development and availability of alternatives
(4) Alternative risk management options
Assessment of the effectiveness and the costs linked to risk
management options
(5) Social implications
Effects of proposed action on, for example, job security and employment
Distribution of costs and benefits on e.g. different population groups, or
different geographical locations
Page 1 of 2
Access to in-
Some
In-depth Know- depth
Field of expertise/experience general
expertise ledgeable expertise at
knowledge
national level
(6) Wider implications
Implications of proposed action on international trade in chemicals,
including international trade rules and WTO compatibility
Implications of proposed action on international trade in chemicals,
effects of countries outside
Implication of proposed restriction or authorisation on Small and Medium
Sized Enterprises
(1) “Proposed action” refers to an application for authorization (see Article 62(5)(a)) or in connection with a proposed restriction (see Article
69(6)(b)
II Risk Management
Access to in-
Some
In-depth Know- depth
Field of expertise/experience general
expertise ledgeable expertise at
knowledge
national level
Knowledge on the risk management measures and operational conditions,
especially on their practicability and effectiveness, related to
Environment
Occupational health and hygiene
Consumer protection
Socio-economic impact of risk management options
Regulatory risk management:
Experience in the regulatory risk management of chemicals under
chemicals legislation
Experience in the regulatory risk management of chemicals under
consumer legislation
Experience in the regulatory risk management of chemicals under
environmental legislation
Experience in the regulatory risk management of chemicals under
occupational health legislation
Other experience in the regulatory risk management of chemicals
(please specify)
Other experience (please specify)
Other risk management options:
Economic instruments
Voluntary approaches
Communication and information
Others (please specify)
III Cross cutting issues
Access to in-
Some
In-depth Know- depth
Field of expertise/experience general
expertise ledgeable expertise at
knowledge
national level
Knowledge of the requirements of titles VII and VIII
Knowledge of REACH provisions and tools, such as exposure scenarios
Knowledge of key issues falling under the responsibility of the Committee for
Risk Assessment
Page 2 of 2
Curriculum Vitae Replace with First name(s) Surname(s)
PERSONAL INFORMATION Replace with First name(s) Surname(s)
[All CV headings are optional. Remove any empty headings.]
Replace with house number, street name, city, postcode, country
Replace with telephone number Replace with mobile number
State e-mail address
State personal website(s)
Replace with type of IM service Replace with messaging account(s)
Sex Enter sex | Date of birth dd/mm/yyyy | Nationality Enter nationality/-ies
JOB APPLIED FOR
POSITION Replace with job applied for / position / preferred job / studies applied
PREFERRED JOB for (delete non relevant headings in left column)
STUDIES APPLIED FOR
WORK EXPERIENCE
[Add separate entries for each experience. Start from the most recent.]
Replace with dates (from - to) Replace with occupation or position held
Replace with employer’s name and locality (if relevant, full address and website)
▪ Replace with main activities and responsibilities
Business or sector Replace with type of business or sector
EDUCATION AND TRAINING
[Add separate entries for each course. Start from the most recent.]
Replace with dates (from - to) Replace with qualification awarded Replace with EQF
(or other) level if
relevant
Replace with education or training organisation’s name and locality (if relevant, country)
▪ Replace with a list of principal subjects covered or skills acquired
PERSONAL SKILLS
[Remove any headings left empty.]
Mother tongue(s) Replace with mother tongue(s)
Other language(s) UNDERSTANDING SPEAKING WRITING
Listening Reading Spoken interaction Spoken production
Replace with language Enter level Enter level Enter level Enter level Enter level
Replace with name of language certificate. Enter level if known.
Replace with language Enter level Enter level Enter level Enter level Enter level
Replace with name of language certificate. Enter level if known.
Levels: A1/2: Basic user - B1/2: Independent user - C1/2 Proficient user
Common European Framework of Reference for Languages
Communication skills Replace with your communication skills. Specify in what context they were acquired. Example:
▪ good communication skills gained through my experience as sales manager
Organisational / managerial skills Replace with your organisational / managerial skills. Specify in what context they were acquired.
Example:
▪ leadership (currently responsible for a team of 10 people)
© European Union, 2002-2013 | http://europass.cedefop.europa.eu Page 1 / 2
Curriculum Vitae Replace with First name(s) Surname(s)
Job-related skills Replace with any job-related skills not listed elsewhere. Specify in what context they were acquired.
Example:
▪ good command of quality control processes (currently responsible for quality audit)
Computer skills Replace with your computer skills. Specify in what context they were acquired. Example:
▪ good command of Microsoft Office™ tools
Other skills Replace with other relevant skills not already mentioned. Specify in what context they were acquired.
Example:
▪ carpentry
Driving licence Replace with driving licence category/-ies. Example:
▪B
ADDITIONAL INFORMATION
Publications Replace with relevant publications, presentations, projects, conferences, seminars, honours and
Presentations awards, memberships, references. Remove headings not relevant in the left column.
Projects Example of publication:
Conferences ▪ How to write a successful CV, New Associated Publishers, London, 2002.
Seminars Example of project:
Honours and awards ▪ Devon new public library. Principal architect in charge of design, production, bidding and construction
Memberships supervision (2008-2012).
References
ANNEXES
Replace with list of documents annexed to your CV. Examples:
▪ copies of degrees and qualifications;
▪ testimonial of employment or work placement;
▪ publications or research.
© European Union, 2002-2013 | http://europass.cedefop.europa.eu Page 2 / 2
NOMINATION FORM BY EU MEMBER STATES AND EEA-EFTA
COUNTRIES FOR MEMBERSHIP OF ECHA COMMITTEES
The nominating country;
wishes to appoint/nominate1 the candidate2 for membership of the following ECHA Committee:
Member State Committee (MSC)
Committee for Risk Assessment (RAC)
Committee for Socio-economic Analysis (SEAC)
Candidate appointed/nominated for:
New membership
Renewal of membership*
Alternate member (for MSC only)
Full name of the appointee/nominee (LAST NAME First name):
Contact details of the appointee/nominee (Address, e-mail, Phone/mobile):
___________________________________________________________________________________
___________________________________________________________________________________
___________________________________________________________________________________
I hereby attach the full CV, the expertise grid and a declaration of interests of the
appointee/nominee (Annexes 4-8 to the cover letter).
___________________________________________________________________________________
*In case of renewal of current membership: I confirm that the following documents provided previously
to ECHA are valid (no changes):
Full CV Expertise grid Declaration of Interest
In line with Article 85(6) of the REACH Regulation, I hereby confirm that the nominating/appointing
Member State shall make all reasonable efforts to provide adequate scientific and technical resources to
the nominated/appointed member, and to enable him/her to use at least half of his/her working time
for this task.
Place: Date:
Signed by3:
1
In accordance with Article 85(3) of the REACH Regulation, each Member State shall appoint one member to MSC. In accordance
with Articles 85(1) and (2) of the REACH Regulation, Member States may nominate candidates for membership of RAC and SEAC.
2
Please fill in one form per candidate.
3
To be signed by the nominating/appointing Member State Competent Authority
(1)
MB/45/2013 final
Helsinki, 27.09.2013
1. Eligibility criteria for members of the Committee for Risk
Assessment and the Committee for Socio-economic
Analysis
As one element to safeguard the independence, integrity and credibility of the outcome of
the ECHA bodies, the ECHA Management Board has put in place a Policy on managing
potential Conflicts of Interest1. This Policy ensures that a balance is taken between getting
the right expertise to guarantee high quality science-based decision and opinion making,
and at the same time strictly avoiding conflicting interests influencing, or seen as
influencing, the decision-making process.
In this respect the ECHA Management Board has adopted the following eligibility criteria
with which candidates for membership in the Committee for Risk Assessment and the
Committee for Socio-economic Analysis have to comply to be considered for appointment2:
• Candidates being currently employed by (in a position of relevant importance), or
holding a position in a governing body (whether paid or unpaid) of a commercial
enterprise with an interest in the field of activity of the Agency shall not be appointed.
Appointed members of the Committees of the Agency shall resign from the Committee
before they enter into service in any such enterprise.
• Candidates being an active member of, or employed by (in a position of relevant
importance), an association or other body (except a body established under public law
of a Member State serving a public interest) which can be considered as an interest
group with an interest in the field of chemicals management shall not be appointed.
Appointed members shall resign from the Committee before they enter into service in
any such association.
• Candidates who personally have contractual obligations with a commercial entity or
interest group with an interest in the field of activity of the Agency after having been
appointed as members, shall (a) withdraw from current contracts and (b) refrain from
entering into any new contracts with such commercial entities or organisations.
• Candidates who currently hold significant investments in a commercial entity
manufacturing, importing or supplying substances or mixtures subject to the authority
of the Agency, including holding of stocks and shares, stock options, equity, bonds,
partnership interest in the capital of such undertaking, one of its subsidiaries or a
company in the capital of which it has a holding 3 or entitling to substantial voting
rights4 in such commercial entity, shall not be appointed. This is without prejudice to
financial interests held through an investment fund, pension fund and/or interests in
1
ECHA Policy on Managing potential Conflicts of Interest (MB/45/2011 final).
2
The scope of the eligibility criteria shall be limited to duty-holders and interest groups under the
REACH, CLP, Biocides and/or PIC Regulation as appropriate taking into account the mandate of the
respective ECHA body. The eligibility criteria apply equally to the interests held by members of the
candidates’ household (i.e. the spouse and dependent children) if significant interests are at stake that
would potentially lead to multiple exclusions of the candidate from the meetings of the Committee or
from rapporteurship.
3
An indicative amount is ca. 100.000,- EUR per commercial entity.
4
An indicative proportion is ca. 20 % voting rights.
2 (6)
non-nominal unit trusts or similar arrangements, provided that these investments are
broadly diversified and the candidate has no influence on their financial management.
• Candidates who were employed by (in a position of relevant importance), or held a
position in a governing body (whether paid or unpaid) of a commercial enterprise with
an interest in the field of activity of the Agency within the past two years shall not be
appointed when the expert has a potential conflict of interest of a general nature that
would potentially lead to multiple exclusions of the individual from the meetings of the
Committee or from rapporteurship. The same applies to candidates who were within
the past two years active member of, or employed by (in a position of relevant
importance), an association or other body (except a body established under public law
of a Member State serving a public interest) which can be considered as an interest
group with an interest in the field of chemicals management.
3 (6)
2. Eligibility criteria for the Executive Director, the
Accounting Officer and of the members of the Board of
Appeal
As one element to safeguard the independence, integrity and credibility of the outcome of
the ECHA bodies, the ECHA Management Board has put in place a Policy on Managing
potential Conflicts of Interest5. This Policy ensures that a balance is taken between getting
the right expertise to guarantee high quality decision-making, and at the same time strictly
avoiding conflicting interests influencing, or seen as influencing, the appeal process.
In this respect the ECHA Management Board has adopted the following eligibility criteria
with which candidates for the position of Executive Director, Accounting Officer or for the
position of regular member of the Board of Appeal have to comply to be considered for
appointment6:
• Candidates who currently hold significant investments in a commercial entity
manufacturing, importing, supplying or placing on the market substances or mixtures
subject to the authority of the Agency, including holding of stocks and shares, stock
options, equity, bonds, partnership interest in the capital of such undertaking, one of
its subsidiaries or a company in the capital of which it has a holding7 or entitling to
substantial voting rights 8 in such commercial entity, shall not be appointed. This is
without prejudice to financial interests held through an investment fund, pension fund
and/or interests in non-nominal unit trusts or similar arrangements, provided that
these investments are broadly diversified and the candidate has no influence on their
financial management.
• Candidates who were employed by (in a position of relevant importance), or held a
position in a governing body (whether paid or unpaid) of a commercial enterprise with
an interest in the field of activity of the Agency within the past two years shall not be
appointed when the candidate has a potential conflict of interest of a general nature
that would potentially lead to multiple exclusions of the individual from the decision-
making of the Agency (in the case of the Executive Director), from the management of
the accounts of the Agency (for the Accounting Officer) or from the decision-making of
the Board of Appeal (for the members of the Board of Appeal). The same applies to
candidates who were within the past two years active member of, or employed by (in
a position of relevant importance), an association or other body (except a body
established under public law of a Member State serving a public interest) which can be
considered as an interest group with an interest in the field of chemicals management.
5
ECHA Policy on Managing potential Conflicts of Interest (MB/45/2011 final).
6
The scope of the eligibility criteria shall be limited to duty-holders and interest groups under the
REACH, CLP, Biocides and/or PIC Regulation as appropriate taking into account the mandate of the
respective ECHA body. The eligibility criteria apply equally to the interests held by members of the
candidates’ household (i.e. the spouse and dependent children) if significant interests are at stake that
would potentially lead to multiple exclusions of the candidate from the decision-making of the Agency
(in the case of the Executive Director), from the management of the accounts of the Agency (for the
Accounting Officer) or from the decision-making of the Board of Appeal (for the members of the Board
of Appeal).
7
An indicative amount is ca. 100.000,- EUR per commercial entity.
8
An indicative proportion is ca. 20 % voting rights.
4 (6)
For candidates for the position of additional or alternate member of the Board of Appeal, the
following additional eligibility criteria apply9:
• Candidates being currently employed by (in a position of relevant importance), or
holding a position in a governing body (whether paid or unpaid) of a commercial
enterprise with an interest in the field of activity of the Agency shall not be appointed.
Appointed members shall resign from the Board of Appeal before they enter into
service in any such enterprise.
• Candidates being an active member of, or employed by (in a position of relevant
importance), an association or other body (except a body established under public law
of a Member State serving a public interest) which can be considered as an interest
group with an interest in the field of chemicals management shall not be appointed.
Appointed members shall resign from the Board of Appeal before they enter into
service in any such association.
• Candidates who personally have contractual obligations with a commercial entity or
interest group with an interest in the field of activity of the Agency after having been
appointed as members of the Board of Appeal, shall (a) withdraw from current
contracts and (b) refrain from entering into any new contracts with such commercial
entities or organisations.
9
The latter three criteria regarding current employment, current membership of an interest group or
other current contractual relationships are not relevant for the candidates for the position of Executive
Director, Accounting Officer or for the position of regular member of the Board of Appeal and do not
apply, as they become ECHA staff members and they will have to comply with the Staff Regulations
for EU officials, and in particular the obligation to receive the approval of the appointing authority for
any outside activity.
5 (6)
3. Eligibility guidelines for members of the Management
Board, the Member State Committee, the Biocidal
Products Committee and the Forum
As one element to safeguard the independence, integrity and credibility of the ECHA
bodies, the ECHA Management Board has put in place a Policy on Managing potential
Conflicts of Interest10. This Policy ensures that a balance is taken between getting the
right expertise to guarantee high quality decision and opinion making, and at the same
time strictly avoiding conflicting interests influencing, or seen as influencing, the
decision-making process.
With the exception of the Commission when appointing the three Management Board
members to represent interested parties, the relevant appointing authorities are thus
invited to respect the ECHA Conflict of Interest Policy and to adhere to the following
guidelines for eligibility for candidates for membership in the Management Board, the
Member State Committee, the Biocidal Products Committee and the Forum11:
• Candidates being currently employed by (in a position of relevant importance), or
holding a position in a governing body (whether paid or unpaid) of a commercial
enterprise with an interest in the field of activity of the Agency should not be
appointed. Appointed members should resign from the ECHA body before they
enter into service in any such enterprise.
• Candidates being an active member of, or employed by (in a position of relevant
importance), an association or other body (except a body established under public
law of a Member State serving a public interest) which can be considered as an
interest group with an interest in the field of chemicals management should not be
appointed. Appointed members shall resign from the ECHA body before they enter
into service in any such association.
• Candidates who personally have contractual obligations with a commercial entity or
interest group with an interest in the field of activity of the Agency after having
been appointed as members, should (a) withdraw from current contracts and (b)
refrain from entering into any new contracts with such commercial entities or
organisations.
• Candidates who currently hold significant investments in a commercial entity
manufacturing, importing, supplying or placing on the market substances or
mixtures subject to the authority of the Agency, including holding of stocks and
shares, stock options, equity, bonds, partnership interest in the capital of such
undertaking, one of its subsidiaries or a company in the capital of which it has a
holding12 or entitling to substantial voting rights13 in such commercial entity, shall
10
ECHA Policy on Managing potential Conflicts of Interest (MB/45/2011 final).
11
The scope of the eligibility guidelines shall be limited to duty-holders and interest groups under
the REACH, CLP, Biocides and/or PIC Regulation as appropriate taking into account the mandate of
the respective ECHA body. The eligibility guidelines apply equally to the interests held by members
of the candidates’ household (i.e. the spouse and dependent children) if significant interests are at
stake that would potentially lead to multiple exclusions of the candidate from the meetings of the
ECHA body or from rapporteurship.
12
An indicative amount is ca. 100.000,- EUR per commercial entity.
13
An indicative proportion is ca. 20 % voting rights.
6 (6)
not be appointed. This is without prejudice to financial interests held through an
investment fund, pension fund and/or interests in non-nominal unit trusts or
similar arrangements, provided that these investments are broadly diversified and
the candidate has no influence on their financial management.
• Candidates who were employed by (in a position of relevant importance), or held a
position in a governing body (whether paid or unpaid) of a commercial enterprise
with an interest in the field of activity of the Agency within the past two years
should not be appointed when the expert has a potential conflict of interest of a
general nature that would potentially lead to multiple exclusions of the individual
from the meetings of the ECHA body or from rapporteurship. The same applies to
candidates who were within the past two years active member of, or employed by
(in a position of relevant importance), an association or other body (except a body
established under public law of a Member State serving a public interest) which can
be considered as an interest group with an interest in the field of chemicals
management.
Tere
Edastan Euroopa Kemikaaliameti kirja, mis on registreeritud meie dokumendisüsteemis nr 14-4/636,
28.03.2018, all.
Tiiu Noobel
Sekretär
Eesti alaline esindus Euroopa Liidu juures
Rue Guimard 11/13, 1040 Brüssel
Tel: + 32 2227 4337
E-post:
[email protected]
http://www.eu.estemb.be/esindus/personal
From: Esindus EL juures üldaadress
Sent: kolmapäev, 28. märts 2018 15:13
To: Tiiu Noobel <
[email protected]>
Subject: FW: Renewal of Membership and new additions in ECHA Committees - Nominations by 8 May
2018
From: ECHA Committees secretariat <
[email protected]>
Sent: kolmapäev, 28. märts 2018 14:49
To:
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; Esindus EL juures üldaadress
<
[email protected]>;
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; '
[email protected]';
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]
Cc:
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; ECHA
Committees secretariat <
[email protected]>;
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; ECHA Management Board
<
[email protected]>;
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected];
[email protected]; ECHA Committees secretariat
<
[email protected]>
Subject: Renewal of Membership and new additions in ECHA Committees - Nominations by 8 May 2018
To the attention of the Permanent Representations of the EU Member States and
EEA/EFTA Countries
Dear Sir/Madam,
Please find attached a letter from the Executive Director of the European Chemicals Agency
(ECHA), Mr Bjorn Hansen, together with annexes.
Yours sincerely,
Marianthi Antonaki
Committees Secretariat
European Chemicals Agency
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland
Tel. +358 (0)9 686 1 8114
[email protected]
http://echa.europa.eu/
http://www.twitter.com/EU_ECHA https://www.facebook.com/EUECHA
https://www.youtube.com/user/EUchemicals
https://www.linkedin.com/company/european-chemicals-agency
The above represents the opinion of the author and is not an official position of the European Chemicals Agency.
This email, including any files attached to it, is intended for the use of the individual to whom it is addressed. If you
have received this message in error, please notify the author as soon as possible and delete the message.
ECHA
EUROPEAN CHEMICALS AGENCY
Helsinki, 27 March 2OtB
1 (2)
D(2018)313s
PRI/ma
Relevant Permanent Representations
of the EU Member States and
EEA/EFTA Countries
Sent by email only
Subject: Renewal and new membership of ECHA Committees (Q3/Q4 2018)
Dear Sir/Madam,
In accordance with the REACH and CLP provisions Member States either appoint (Member
State Committee - MSC) or nominate (Committee for Risk Assessment - RAC and Committee
for Socio-economic Analysis - SEAC) the candidates for membership of the Committee, I am
herewith launching the process for:
¡ renewing membership when the term of office ends by 31 December 2018, and
. appointment/nomination of new members.
Annex 1 provides the names of the current members whose term of office is about to end and
the list of vacancies is contained in Annex 2.
On behalf of ECHA, I would like to express my encouragement to the Member State Competent
Authorities (MSCAs) to continue to support the work of the members of these bodies, which
have a continuously increasing workload,
1. Renewal of Committee Membership
Through this letter you are kindly invited to submit to ECHA, no later than 8 May 2O18, your
appointments/nominations to renew the 3-year membership period of the current members
indicated in Annex 1 to:
[email protected] together with the
information in the Annexes.
For those members whose term of office ends after 31 December 2018, no action on your part
is required at this stage.
2. Appointment of new members - MSC
In accordance with the REACH Regulationl, each Member State shall appoint one member to
MSC, A Member State has the possibility to appoint a new member at any point, However,
please note that ECHA will assume that the appointed (new) member will start from the end of
the term of office of the current member, unless otherwise stated in the appointment letter2,
Members are expected to dedicate at least 30%o of their work time to MSC,
In the case of the MSC and in accordance with its Rules of Procedure, you may also consider
the possibility of appointing an alternate member to the formally appointed MSC member. To
do so, please follow the same instructions as for appointing a member to the MSC.
3. Nomination of new candidates for membership - RAC and SEAC
In accordance with the REACH Regulation3, Member States may nominate candidates for
membership of RAC and SEAC. The Management Board (MB) shall appoint the members of
each Committee, including at least one but no more than two members of each Member State
1
Articte 85(3).
2 For UK the appointment is for the period until the UK withdrawalfrom the EU on 30 March 2019.
3 Articles
85(1) and (2).
Annankatu 18, P.O. Box 400, FI-00121 Helsink¡, Finland I Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu
2 (2)
that has nominated candidates, Members are to be appointed for their role and experience in
performing the tasks specified in Article 77(3) of the REACH Regulation.
You are encouraged to liaise with the Chairmen of RAC and SEAC, respectively, to discuss
suitable profiles for nominated candidates.
Member States are invited to nominate a sufficient number of experts covering different areas
of competencies in order to allow the MB to ensure that RAC and SEAC have full capacity and
cover all fields of required expertise. The members are appointed in their individual capacity as
scientific experts. However, Article 85(6) of the REACH Regulation states that the MS shall
provide adequate scientific and technical resources to the members of the Committees that
they have nominated. This gives RAC and SEAC their unique character.
All members of RAC and SEAC are required to take on the crucial role of rapporteur and draft
the scientific opinion of the Committee on specific cases submitted by a Member State, the
European Commission or a company. Commenting on draft opinions circulated for Committee
consultation is an equally important task. Members are expected to provide at least S0olo
of their time to the work of the Committees and the nominating MSCA guarantees
this by signing Annex 3 of the nomination papers. It is therefore necessary that the
working time of the nominated member allocated by his or her employer (Agency, Ministry or
Institute) is sufficient to allow the member to carry out their duties. Support by other staff
from the Competent Authority in providing complementary expertise to assess all aspects of
the case at hand is also a pre-requisite for success.
ECHA will process any personal data received in accordance with Regulation (EC) No 4512001
on the protection of individuals with regard to the processing of personal data by the EU
institutions and bodies,
If you have any questions concerning the nominations or appointments, please contact Pilar
Rodríguez lglesias, Head of Unit of the Committees Secretariat at:
Pilar.
[email protected].
Yours faithful ly,
Bjo Han n
tve irector
Cc REACH Competent Authorities of the Member States
Secretariat of the ECHA Management Board
Members of ECHA Committees listed in Annex 1
Encls. Annex 1 Members of the Committees whose term of office will expire between 1 July
and 31 December 2018
Annex 2 List of vacant positions on the three Committees
Annex 3 Nomination/Appointment form
Annex 4 Background paper on MSC
Annex 5 Background paper on RAC (with the expertise grid)
Annex 6 Background paper on SEAC (with the expertise grid)
Annex 7 ECHA Declaration of Interests
Annex 8 Europass CV template
Annex 9 Eligibility criteria (RAC, SEAC and MSC)
Annankatu 18, P.O. Box 400, FI-00121 Helsinki, Finland I Tel. +358 9 686180 | Fax +358 9 68618210 | echa.europa.eu
1(2)
Annex 2 - List of vacant positions on the three Committees
Number of members Current number of
Country Committee Number of vacants
allowed members
Austria RAC 2 2 0
Austria SEAC 2 2 0
Belgium RAC 2 1 1
Belgium SEAC 2 2 0
Bulgaria RAC 2 2 0
Bulgaria SEAC 2 1 1
Croatia RAC 2 1 1
Croatia SEAC 2 1 1
Cyprus RAC 2 2 0
Cyprus SEAC 2 2 0
Czech Republic RAC 2 2 0
Czech Republic SEAC 2 1 1
Denmark RAC 2 2 0
Denmark SEAC 2 1 1
Estonia RAC 2 1 1
Estonia SEAC 2 1 1
Finland RAC 2 2 0
Finland SEAC 2 1 1
France RAC 2 2 0
France SEAC 2 2 0
Germany RAC 2 2 0
Germany SEAC 2 2 0
Greece RAC 2 2 0
Greece SEAC 2 0 2
Hungary RAC 2 2 0
Hungary SEAC 2 1 1
Iceland MSC 1 0 1
Iceland RAC 2 2 2
Iceland SEAC 2 0 2
Ireland RAC 2 2 0
Ireland SEAC 2 0 2
Italy RAC 2 2 0
Italy SEAC 2 2 0
Latvia RAC 2 1 1
Latvia SEAC 2 2 0
Liechtenstein MSC 1 0 1
Liechtenstein RAC 2 0 2
Liechtenstein SEAC 2 0 2
Lithuania RAC 2 2 0
Lithuania SEAC 2 2 0
Luxembourg RAC 2 2 0
Luxembourg SEAC 2 0 2
Malta RAC 2 0 2
Malta SEAC 2 0 2
Netherlands RAC 2 2 0
Netherlands SEAC 2 2 0
Norway RAC 2 2 0
Norway SEAC 2 0 2
Poland RAC 2 2 0
Poland SEAC 2 1 1
2(2)
Portugal RAC 2 1 1
Portugal SEAC 2 1 1
Romania RAC 2 2 0
Romania SEAC 2 1 1
Slovakia RAC 2 1 1
Slovakia SEAC 2 0 2
Slovenia RAC 2 2 0
Slovenia SEAC 2 1 1
Spain RAC 2 2 0
Spain SEAC 2 1 1
Sweden RAC 2 2 0
Sweden SEAC 2 1 1
United Kingdom RAC 2 2 0
United Kingdom SEAC 2 2 0
ECHA DECLARATION OF INTEREST
There is a conflict of interest where the impartiality and objectivity of a decision, opinion
or recommendation of the Agency and/or its bodies, is or might in the public perception be
compromised by an interest held by, or entrusted to, an individual working for the Agency.
Please note that having an interest does not necessarily mean having a conflict of interest.
In particular, high quality of (scientific) expertise is by nature based on prior experience.
Declaring an interest does therefore not automatically disqualify you or limit your
participation in the activities of the European Chemicals Agency.
On the other hand it should be emphasised that this declaration of interest form does not
contain an exhaustive list of potential interests and that all other elements that might
jeopardise your independence when working with the Agency should thus also be
indicated. Your answers will then be reviewed and dealt with in accordance with the ECHA
Procedure for Prevention and Management of potential Conflicts of Interest.
Declaration of Commitment
I hereby declare that I shall make all reasonable efforts to fulfil my duties related to the
work of the European Chemicals Agency.
Declaration of Interests
First Name:
Last name:
Position in ECHA:
hereby declares to have the following interests:
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 1 of 6
I. Employment, consultancy, legal representation or advice
Within the past 5 years, were you employed or have you had any other professional
relationship with a commercial entity1 or other organisation2 with an interest in the
regulatory field of activity of ECHA?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or commercial
entity
II. Membership of Governing Body, Scientific Advisory Body or
equivalent structure
Within the past 5 years, have you participated in the internal decision-making of a
commercial entity or other organisation with an interest in the regulatory field of activity
of ECHA (e.g. board membership, directorship) or have you participated in the works of a
Scientific Advisory Body with voting rights on the outputs of that entity?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or commercial
entity
1
This includes any commercial business, consultancy, research institution or other enterprise whose funding is
significantly derived from commercial sources. It also includes independent own commercial businesses, law
offices, consultancies or similar.
2
An ‘organisation’ includes governmental, international or non-profit organisations, as well as interest groups.
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 2 of 6
III. Other membership or affiliation
Within the past 5 years, have you had any membership or affiliation other than the above
that can be perceived as creating a potential conflict of interest?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or commercial
entity
IV. Research funding
Within the past 5 years, have you or the research entity to which you belong received any
support from a commercial entity or other organisation with an interest in the regulatory
field of activity of ECHA, including grants, rents, sponsorships, fellowships, non-monetary
support?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or commercial
entity
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 3 of 6
V. Investments
Do you have current investments in a commercial entity with an interest in the regulatory
field of activity of ECHA, including holding of stocks and shares, stock options, equity,
bonds, partnership interest in the capital of such undertaking, one of its subsidiaries or a
company in the capital of which it has a holding and which amounts to more than 10,000
EUR per commercial entity or entitling you to a voting right of 5% or more in such
commercial entity?3
No
Yes, and more in particular:
Investment Name of organisation or commercial
entity
VI. Intellectual Property
Do you have any intellectual property rights (e.g. patent, trademark, copyright or
proprietary know-how) in the regulatory field of activity of ECHA that might create a
potential conflict of interest?
No
Yes, and more in particular:
Intellectual Property Name of Description
organisation or
commercial
entity
3
You may exclude financial interests held through an investment fund, pension fund and/or interests in non-
nominal unit trusts or similar arrangements, provided that these investments are broadly diversified and you
have no influence on their financial management.
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 4 of 6
VII. Public statements and positions
Within the past 5 years, have you provided any expert opinion or testimony in the
regulatory field of activity of ECHA for a commercial entity or other organisation as part of
a regulatory, legislative or judicial process? Have you held an office or other position, paid
or unpaid, where you represented interests or defended an opinion in the regulatory field
of activity of ECHA?
No
Yes, and more in particular:
Function/Activity Time period Name of Description
(from…until organisation
month/year) or commercial
entity
VIII. Other relevant information
Are there any other elements that could be seen as jeopardising your independence when
working for the Agency?
No
Yes, and more in particular:
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 5 of 6
IX. Interests held by close family members4
Do any of your close family members hold any current interests in the regulatory field of
activity of the Agency (as specified above in the sections I.-VIII.)?
No
Yes, and more in particular:
Function/Activity Name of organisation Description
or commercial entity
I wish to have any reference to interests held by close family members removed if this
declaration is to be made public on the ECHA website. 5
I hereby declare that I have read both the ECHA Procedure on Prevention and
Management of potential Conflicts of Interest and the related ECHA Guidance
document and that the above Declaration of Interest is at my best knowledge
complete. I understand that for all members of the ECHA bodies, the Executive Director
and the other ECHA management staff (Directors and Heads of Unit), as well as for the
chairpersons of the ECHA Committees this declaration will be published on the ECHA
website.
Please note that the European Chemicals Agency will ensure on its part that your personal
data hereby submitted is processed as required by Regulation (EC) No 45/2001 on the
protection of individuals with regard to the processing of personal data by the Community
institutions and bodies and on the free movement of such data. The data is necessary for
the purpose of implementing the Agency’s Procedure for Prevention and Management of
potential Conflicts of Interest and will be retained for a time period of 7 years. You have
the right to access and rectify that data. Under certain conditions, a right to erasure,
restriction, objection and/or data portability also applies. To exercise these rights, please
contact the relevant secretariat. You can contact the Agency’s Data Protection Officer for
any questions or complaints with regard to the processing of your personal data. In case
you do not receive a satisfactory outcome, you can have recourse to the European Data
Protection Supervisor.
Date:
4
For this purpose, ‘close family members’ are considered to be the persons forming a household with the
person making this declaration (spouse, partner, and/or dependent children). For privacy reasons neither the
relationship nor the name is to be included. Only current interests held by close family members are of relevance
and not past interests.
5
As full transparency is one of the general principles of this Procedure, this option should only be used in case
the consent of the individual concerned has not been obtained, when he/she has objected to the disclosure on
compelling legitimate grounds or if there is reason to believe that the legitimate interests of the individual
involved might be prejudiced by the disclosure (see also Regulation (EC) No 45/2001 on the protection of
personal data).
FOR-0039.04
Uncontrolled copy once printed. Ensure that the right version is in use. Page 6 of 6